Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients.

[1]  A. Nissenson,et al.  Treatment compliance in end-stage renal disease patients on dialysis. , 1986, American journal of nephrology.

[2]  A. Collins,et al.  Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  E. Freis,et al.  Partial reduction of blood pressure and prevention of complications in hypertension. , 1974, The New England journal of medicine.

[4]  A. Santoro,et al.  Pathogenesis of hypertension in hemodialysis patients: a pharmacological study. , 1988, Kidney international. Supplement.

[5]  Y. Berland,et al.  Anaphylactoid reactions during hemodialysis and hemofiltration: role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  K. Iseki,et al.  Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. , 1993, Kidney international.

[7]  L. Kuller,et al.  Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. , 1988, Circulation.

[8]  J. Brown,et al.  Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system. , 1973, The American journal of medicine.

[9]  K. Iseki,et al.  Predictors of stroke in patients receiving chronic hemodialysis. , 1996, Kidney international.

[10]  L. Berman,et al.  Hypertension in end-stage renal disease. , 1969, The New England journal of medicine.

[11]  J. Adamson,et al.  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. , 1987, The New England journal of medicine.

[12]  L. Moore,et al.  Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. , 1983, Kidney international. Supplement.

[13]  E. Lowrie,et al.  Cardiovascular Disease in Dialysis Patients , 1974 .

[14]  David C. Murray,et al.  Outcome and risk factors of ischemic heart disease in chronic uremia. , 1996, Kidney international.

[15]  C. Bulpitt,et al.  How far should blood pressure be lowered? , 1992, The New England journal of medicine.

[16]  R. Strawderman,et al.  Logical and statistical fallacies in the use of Cox regression models. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  R. Hardy,et al.  The impact of selected indices of antihypertensive treatment on all-cause mortality. , 1983, American journal of epidemiology.

[18]  K. Iseki,et al.  Hypertension in dialysis patients: a cross-sectional analysis. , 1996, Nihon Jinzo Gakkai shi.

[19]  K. Iseki,et al.  Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). , 1993, Kidney international.

[20]  A. Iaina,et al.  Probability of survival in hypertensive and nonhypertensive patients on maintenance hemodialysis. , 1977, Israel journal of medical sciences.

[21]  J. Neel,et al.  Blood Pressure, Sodium Intake, and Sodium Related Hormones in the Yanomamo Indians, a “No‐salt” Culture , 1975, Circulation.

[22]  P. Degoulet,et al.  Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. , 1982, Nephron.

[23]  B. Charra,et al.  Control of hypertension and prolonged survival on maintenance hemodialysis. , 1983, Nephron.

[24]  K. Iseki,et al.  Impact of the initial levels of laboratory variables on survival in chronic dialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  D. Churchill,et al.  Canadian Hemodialysis Morbidity Study. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  B. Charra,et al.  Survival as an index of adequacy of dialysis. , 1992, Kidney international.

[27]  J. H. Acosta.  Hypertension in chronic renal disease. , 1982, Kidney international.

[28]  A. Bellucci,et al.  Mortality in dialysis patients: analysis of the causes of death. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  O. Salvatierra,et al.  The role of hypertension in hemodialysis-associated atherosclerosis. , 1980, The American journal of medicine.

[30]  E G Lowrie,et al.  Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  A. Rubin,et al.  Hypertension is not adequately controlled in hemodialysis patients. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  B. Scribner,et al.  Accelerated atherosclerosis in prolonged maintenance hemodialysis. , 1974, The New England journal of medicine.

[33]  David C. Murray,et al.  Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. , 1996, Kidney international.

[34]  K. Iseki,et al.  Serum albumin is a strong predictor of death in chronic dialysis patients. , 1993, Kidney international.

[35]  T. Andreoli,et al.  Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. , 1979, Kidney international.